BIT
PTLA

BlackRock Institutional Trust’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BlackRock Institutional Trust’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$32.9M Buy
1,465,381
+63,115
+5% +$1.23M ﹤0.01% 1605
2016
Q3 		$31.8M Buy
1,402,266
+50,984
+4% +$1.2M 0.01% 1579
2016
Q2 		$31.9M Sell
1,351,282
-135,776
-9% -$3.35M 0.01% 1532
2016
Q1 		$30.3M Buy
1,487,058
+175,109
+13% +$5.56M 0.01% 1537
2015
Q4 		$67.5M Buy
1,311,949
+94,389
+8% +$4.58M 0.01% 1067
2015
Q3 		$51.9M Buy
1,217,560
+246,383
+25% +$11.9M 0.01% 1209
2015
Q2 		$44.2M Buy
971,177
+141,818
+17% +$5.71M 0.01% 1368
2015
Q1 		$31.5M Buy
829,359
+241,385
+41% +$8.29M ﹤0.01% 1617
2014
Q4 		$16.7M Buy
587,974
+188,088
+47% +$5.23M ﹤0.01% 2025
2014
Q3 		$10.1M Sell
399,886
-631
-0.2% -$16.6K ﹤0.01% 2333
2014
Q2 		$11.7M Buy
400,517
+135,818
+51% +$3.29M ﹤0.01% 2331
2014
Q1 		$6.86M Buy
264,699
+85,208
+47% +$2.27M ﹤0.01% 2637
2013
Q4 		$4.62M Sell
179,491
-16,373
-8% -$398K ﹤0.01% 2825
2013
Q3 		$5.24M Sell
195,864
-11,778
-6% -$280K ﹤0.01% 2709
2013
Q2 		$5.1M Buy
+207,642
New +$4.13M ﹤0.01% 2689

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's PTLA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 4.5% in Q4 2016, buying an estimated $1.23M and bringing the position to 1,465,381 shares worth $32.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

BlackRock Institutional Trust first reported a position in PTLA in Q2 2013 and has held it in 15 quarters since. The position peaked at $67.5M in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

  • BlackRock Institutional Trust held 1,465,381 shares of Portola Pharmaceuticals, Inc. worth $32.9M as of Q4 2016.
  • BlackRock Institutional Trust bought 63,115 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.23M.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1605 holding.
  • BlackRock Institutional Trust first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Portola Pharmaceuticals, Inc. position peaked at $67.5M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.